191 related articles for article (PubMed ID: 37106027)
1. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.
Loh JW; Lee JY; Lim AH; Guan P; Lim BY; Kannan B; Lee ECY; Gu NX; Ko TK; Ng CC; Lim JCT; Yeong J; Lim JQ; Ong CK; Teh BT; Chan JY
Commun Biol; 2023 Apr; 6(1):461. PubMed ID: 37106027
[TBL] [Abstract][Full Text] [Related]
2. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract][Full Text] [Related]
3. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586
[TBL] [Abstract][Full Text] [Related]
4. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
5. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
[TBL] [Abstract][Full Text] [Related]
6. Towards precision oncology in angiosarcomas using next generation "omic" technologies.
Tan GF; Chan JY
Oncotarget; 2021 Sep; 12(19):1953-1955. PubMed ID: 34548911
[TBL] [Abstract][Full Text] [Related]
7. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas.
Weidema ME; van de Geer E; Koelsche C; Desar IME; Kemmeren P; Hillebrandt-Roeffen MHS; Ho VKY; van der Graaf WTA; Versleijen-Jonkers YMH; von Deimling A; Flucke UE;
Clin Cancer Res; 2020 Jan; 26(1):93-100. PubMed ID: 31562204
[TBL] [Abstract][Full Text] [Related]
9. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
[TBL] [Abstract][Full Text] [Related]
10. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Boichard A; Wagner MJ; Kurzrock R
Genome Med; 2020 Jul; 12(1):61. PubMed ID: 32646514
[TBL] [Abstract][Full Text] [Related]
11. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
12. Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups.
Tomassen T; Weidema ME; Hillebrandt-Roeffen MHS; van der Horst C; ; Desar IME; Flucke UE; Versleijen-Jonkers YMH
Immunol Res; 2022 Apr; 70(2):256-268. PubMed ID: 35043369
[TBL] [Abstract][Full Text] [Related]
13. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck.
Domfeh AB; Fichera M; Hunt JL
Arch Pathol Lab Med; 2006 Aug; 130(8):1184-7. PubMed ID: 16879020
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
16. Machine learning application identifies novel gene signatures from transcriptomic data of spontaneous canine hemangiosarcoma.
Cheng N; Schulte AJ; Santosa F; Kim JH
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33078825
[TBL] [Abstract][Full Text] [Related]
17. Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis.
Espejo-Freire AP; Elliott A; Rosenberg A; Costa PA; Barreto-Coelho P; Jonczak E; D'Amato G; Subhawong T; Arshad J; Diaz-Perez JA; Korn WM; Oberley MJ; Magee D; Dizon D; von Mehren M; Khushman MM; Hussein AM; Leu K; Trent JC
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638300
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
Suchak R; Thway K; Zelger B; Fisher C; Calonje E
Am J Surg Pathol; 2011 Jan; 35(1):60-9. PubMed ID: 21164288
[TBL] [Abstract][Full Text] [Related]
19.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
